Pulmonary artery hypertension: an underrated disease manifestation in cystic fibrosis?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The Lancet Respiratory Medicine

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S2213-2600(16)30107-2PMID 27298018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study

  2016cited by this paper
• Main Pulmonary Artery-to-Ascending Aorta Diameter Ratio in Healthy Children on MDCT.

  2015cited by this paper
• Cystic fibrosis

  2015cited by this paper
• Impact of pulmonary hypertension on survival in patients with cystic fibrosis undergoing lung transplantation: an analysis of the UNOS registry.

  2014cited by this paper
• Pulmonary hypertension in cystic fibrosis with advanced lung disease.

  2014cited by this paper
• CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.

  2014cited by this paper
• Correlation Between Computed Tomography Expression of Pulmonary Hypertension and Severity of Lung Disease in Cystic Fibrosis Patients

  2013cited by this paper
• Pulmonary arterial enlargement and acute exacerbations of COPD.

  2012cited by this paper
• Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival.

  2010cited by this paper
• Cystic Fibrosis

  2009cited by this paper

• Pulmonary arteriole narrowing in end-stage cystic fibrosis lungs occurs with and without small airway disease.

  2025cites this paper
• Pulmonary hypertension associated with lung diseases

  2024cites this paper
• Mechanisms underlying the roles of leukocytes in the progression of cystic fibrosis

  2024cites this paper
• Proinflammatory indicators and the relevance of echocardiography in children with cystic fibrosis.

  2023cites this paper
• Cardiovascular complications in cystic fibrosis: A review of the literature.

  2021cites this paper
• Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension

  2021cites this paper
• Cardiac Involvement in Mild Cystic Fibrosis Lung Involvement Assessed by Tissue‐Doppler Echocardiography

  2019cites this paper
• Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health

  2017cites this paper